Description References
ChemicalBook > CAS DataBase List > Verapamil hydrochloride

Verapamil hydrochloride

Description References
Product Name
Verapamil hydrochloride
CAS No.
23313-68-0
Chemical Name
Verapamil hydrochloride
Synonyms
CALAN;ISOPTIN;Veracim;Veramex;Zolvera;Dignover;Berkatens;Cardibeltin;IPROVERATRIL;VERAPAMIL HCL
CBNumber
CB9460012
Molecular Formula
C27H39ClN2O4
Formula Weight
491.06
MOL File
23313-68-0.mol
More
Less

Verapamil hydrochloride Property

Melting point:
142 °C (dec.)(lit.)
storage temp. 
0-6°C
solubility 
methanol: 50 mg/mL, clear, colorless
form 
powder
color 
white
BCS Class
1,2
CAS DataBase Reference
23313-68-0(CAS DataBase Reference)
More
Less

Safety

Hazard Codes 
T,Xi
Risk Statements 
23/24/25-36/37/38
Safety Statements 
36/37-45-37/39-26
RIDADR 
UN 2811 6.1/PG 3
WGK Germany 
3
RTECS 
YV8320000
8-10
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Tocris
Product number
0654
Product name
Verapamil hydrochloride
Purity
≥99%(HPLC)
Packaging
1G
Price
$103
Updated
2021/12/16
Usbiological
Product number
257041
Product name
Verapamil hydrochloride
Packaging
1g
Price
$347
Updated
2021/12/16
Usbiological
Product number
V2121-49L
Product name
Verapamil Hydrochloride
Packaging
5g
Price
$403
Updated
2021/12/16
Usbiological
Product number
291917
Product name
Verapamil hydrochloride
Packaging
50g
Price
$425
Updated
2021/12/16
Medical Isotopes, Inc.
Product number
14158
Product name
VerapamilHCl
Packaging
25g
Price
$1760
Updated
2021/12/16
More
Less

Verapamil hydrochloride Chemical Properties,Usage,Production

Description

Verapamil hydrochloride (VRP) is a phenylalkylamine calcium ion influx inhibitor (calcium antagonist). Verapamil hydrochloride exerts its pharmacologic effects by modulating the influx of ionic through the slow channels of vascular smooth muscle and cardiac cell membranes. It is widely used for the treatment of hypertension, angina pectoris, supraventricular tachycardia, myocardial infraction, and vascular headaches. Verapamil has also been used in cell biology as an inhibitor of drug efflux pump proteins such as P-glycoprotein, which are often over-expressed in certain tumor cell lines The plasma half-life of verapamil hydrochloride is 2–7 hours, which necessitates multiple dosing. After oral administration of VRP to humans, the drug is rapidly absorbed and widely distributed. It is approximately 90% absorbed from the gastrointestinal tract but is subject to considerable first pass metabolism and its bioavailability is around 20–30%. The low bioavailability is owing to the rapid biotransformation in the liver with a biological half-life of 4.0±1.5 hours.

References

[1] https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3bee2d26-138c-4641-a217-a38d3d657461
[2] V. Kusum Devi, S. Saisivam, G. R. Maria, P. U. Deepti (2003) Design and Evaluation of Matrix Diffusion Controlled Transdermal Patches of Verapamil Hydrochloride, 29, 495-503.
[3] https://www.caymanchem.com/product/14288
[4] Yuveraj Singh Tanwar, Pushpendra Singh Naruka, Garima Rani Ojha (2007) Development and evaluation of floating microspheres of verapamil hydrochloride, 43, 529-534

Chemical Properties

White Powder

Uses

A calcium channel blocker. Antihypertensive; antianginal; antiarrhythmic (class IV)

Uses

Calcium antagonists

brand name

Calan (Searle); Covera (Searle); Isoptin (FSC); Isoptin (Par); Verelan (Elan).

Clinical Use

Calcium-channel blocker:
Supraventricular arrhythmias
Angina
Hypertension
Cluster headaches (unlicensed)

Veterinary Drugs and Treatments

Veterinary experience with this agent is somewhat limited, but in dogs and cats verapamil may be useful for supraventricular tachycardias and, possibly, treatment of atrial flutter or fibrillation.

Drug interactions

Potentially hazardous interactions with other drugs
Aminophylline and theophylline: enhanced effect of aminophylline and theophylline.
Anaesthetics: increased hypotensive effect.
Anti-arrhythmics: increased risk of amiodaroneinduced bradycardia, AV block and myocardial depression; increased risk of myocardial depression and asystole with disopyramide and flecainide; increased risk of bradycardia and myocardial depression with dronedarone.
Antibacterials: metabolism increased by rifampicin; metabolism possibly inhibited by erythromycin, clarithromycin and telithromycin (increased risk of toxicity).
Anticoagulants: possibly increases dabigatran concentration - reduce dabigatran dose.
Antidepressants: enhanced hypotensive effect with MAOIs; concentration of imipramine and possibly other trycyclics increased; concentration significantly reduced by St John’s wort.
Antiepileptics: effect probably reduced by barbiturates, phenytoin and primidone; enhanced effect of carbamazepine.
Antifungals: negative inotropic effect possibly increased with itraconazole.
Antihypertensives: enhanced hypotensive effect, increased risk of first dose hypotensive effect of postsynaptic alpha-blockers.
Antipsychotics: possibly increases concentration of lurasidone.
Antivirals: concentration possibly increased by atazanavir and ritonavir; use telaprevir with caution.
Avanafil: concentration of avanafil increased.
Beta-blockers: enhanced hypotensive effect; risk of asystole, severe hypotension and heart failure if coprescribed with beta-blockers.
Cardiac glycosides: increased levels of digoxin. Increased AV block and bradycardia.
Ciclosporin: variable reports of decreased nephrotoxicity and potentiated effect; may also increase ciclosporin levels.
Colchicine: possibly increased risk of colchicine toxicity - suspend or reduce colchicine, avoid concomitant use in renal or hepatic failure.
Cytotoxics: possibly increased bosutinib, doxorubicin, ibrutinib concentration - reduce dose of bosutinib and ibrutinib; possibly increased risk of bradycardia with crizotinib; concentration of both drugs may be increased in combination with everolimus - consider reducing everolimus dose; concentration of olaparib possibly increased - avoid or reduce olaparib dose.
Fingolimod: increased risk of bradycardia.
Grapefruit juice: concentration increased - avoid concomitant use.
Ivabradine: concentration of ivabradine increased - avoid concomitant use.
Lenalidomide: possibly increases lenalidomide concentration.
Lipid-lowering agents: increased myopathy with atorvastatin and simvastatin - reduce dose of atorvastatin, do not exceed 20 mg of simvastatin1 , concentration of verapamil increased by atorvastatin; concentration of lomitapide increased - avoid.
Sirolimus: concentration of both drugs increased.
Tacrolimus: may increase tacrolimus levels.

Metabolism

Verapamil undergoes considerable first pass loss and is extensively metabolised in the liver. 12 metabolites have been identified. Of these only norverapamil has any significant activity (approximately 20
% that of the parent compound). Norverapamil represents about 6
% of the dose eliminated in urine and reaches steady-state plasma concentrations approximately equal to those of verapamil. About 70
% of a dose is excreted by the kidneys in the form of its metabolites but about 16
% is excreted in the bile into the faeces. Less than 4
% is excreted unchanged.

Purification Methods

The salt is purified by dissolving it in EtOH, filtering (if insoluble particles are present) and adding Et2O, filtering the salt, washing it with Et2O and drying it in vacuo. It has the following solubilities: hexane (0.001%), CH2Cl2 (~10%), MeOH (~10%), EtOH (20%) and H2O (8.3%). It has UV max at 232 and 278nm. The free base is a viscous yellow oil b 243-246o/0.01mm (n 25D 1.5448) and is almost insoluble in H2O but soluble in organic solvents. It is a Ca channel antagonist and is a coronary vasodilator. [Ramuz Helv Chim Acta 58 2050 1975, Harvey et al. Biochem J 257 95 1989.]

Verapamil hydrochloride Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Verapamil hydrochloride Suppliers

3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Fax
86-21-50328109
Email
3bsc@sina.com
Country
China
ProdList
15838
Advantage
69
Beijing Ouhe Technology Co., Ltd
Tel
010-010-82967028 13522913783
Fax
+86-10-82967029
Email
2355560935@qq.com
Country
China
ProdList
12000
Advantage
60
Chemsky (shanghai) International Co.,Ltd
Tel
021-50135380
Email
shchemsky@sina.com
Country
China
ProdList
15402
Advantage
60
Syntechem Co.,Ltd
Tel
Fax
E-Mail Inquiry
Email
info@syntechem.com
Country
China
ProdList
12984
Advantage
57
Wuhan Fortuna Chemical Co., Ltd
Tel
027-59207852 13308628970
Fax
QQ3130921841
Email
buy@fortunachem.com
Country
China
ProdList
2766
Advantage
58
S.Z. PhyStandard Bio-Tech. Co., Ltd.
Tel
0755-83725681-603
Fax
+86 755 28094224
Country
China
ProdList
4496
Advantage
50
Shanghai TaoSu Biochemical Technology Co., Ltd.
Tel
021-33632979
Fax
021-34692979
Email
info@tsbiochem.com
Country
China
ProdList
8065
Advantage
58
Struchem Co., Ltd.
Tel
0512-63009836 18994340901
Fax
0512-63006936
Email
helen@struchem.com
Country
China
ProdList
3981
Advantage
60
Shanghai Qiao Chemical Science Co., Ltd
Tel
021-58892003
Email
info@qiaochem.com
Country
China
ProdList
6059
Advantage
65
Guangzhou QiYun Biotechnology Co., Ltd.
Tel
020-61288194 61288195
Fax
020-61288700
Email
505721671@qq.com
Country
China
ProdList
3866
Advantage
58
Cangzhou Enke Pharma-tech Co., Ltd.
Tel
0317-5296180 15533709196
Fax
0317-5106596
Email
sale@enkepharma.com
Country
China
ProdList
2247
Advantage
55
Beijing Solarbio Science & Tecnology Co., Ltd.
Tel
17801761073
Email
3193328036@qq.com
Country
China
ProdList
6338
Advantage
68
Amadis Chemical Company Limited
Tel
571-89925085
Fax
0086-571-89925065
Email
sales@amadischem.com
Country
China
ProdList
131957
Advantage
58
Wuhan Magic Biological Technology Co., Ltd.
Tel
18872289958、027-52304252、3400508168
Fax
027-52304252
Email
3400508168@qq.com
Country
China
ProdList
1910
Advantage
55
Wuhan Zonvsicom chemicals Co.,Ltd.
Tel
15623071665
Fax
027-59257948
Email
sales@zvsicom.com
Country
China
ProdList
299
Advantage
58
Hubei Xinyuanshun Pharmaceutical Chemical Co., Ltd.
Tel
027-51831887 15337167856
Fax
027-51837635 QQ1165326703
Email
hubeixinyuanshun@163.com
Country
China
ProdList
10295
Advantage
58
Hefei TNJ Chemical Industry Co.,Ltd.
Tel
+86-0551-65418671 +8618949823763
Fax
0551-65418697
Email
sales@tnjchem.com
Country
China
ProdList
34563
Advantage
58
Wuhan Fortuna Chemical Co., Ltd
Tel
+86-027-59207850 +86-13986145403;
Fax
86-27-59524646
Email
info@fortunachem.com
Country
China
ProdList
5986
Advantage
58
Xi'an ZB Biotech Co.,Ltd
Tel
Email
sales03@xazbbio.com
Country
CHINA
ProdList
719
Advantage
58
Baoji Guokang Healthchem Co., Ltd.
Tel
+86-0917-3909592 +86-13892490616
Fax
09173909592
Email
gksales1@gk-bio.com
Country
China
ProdList
9209
Advantage
58
Shaanxi Dideu Medichem Co. Ltd
Tel
+86-029-89586680 +86-18192503167
Fax
+86-29-88380327
Email
1026@dideu.com
Country
China
ProdList
8025
Advantage
58
Longyan Tianhua Biological Technology Co., Ltd
Tel
0086 18039857276 18039857276
Country
CHINA
ProdList
2783
Advantage
58
career henan chemical co
Tel
+86-0371-86658258 +8613203830695
Fax
0086-371-86658258
Email
factory@coreychem.com
Country
China
ProdList
29798
Advantage
58
Energy Chemical
Tel
021-58432009 400-005-6266
Fax
021-58436166
Email
marketing1@energy-chemical.com
Country
China
ProdList
44894
Advantage
58
Wuhan Yanzhe Technology Co., Ltd
Tel
15527250409
Fax
QQ:2692360204
Email
wenhaotian12@163.com
Country
China
ProdList
4171
Advantage
58
Nanjing Shizhou Biology Technology Co.,Ltd
Tel
13675144456
Fax
025-85563444
Email
sean.lv@synzest.com
Country
China
ProdList
10784
Advantage
58
TCI (Shanghai) Chemical Trading Co., Ltd.
Tel
021-61109150
Fax
021-61105897
Email
sales@tcisct.com
Country
China
ProdList
29668
Advantage
58
Hubei Chenxin Pharmaceutical Co., Ltd.
Tel
17362916295 17362916295;
Fax
QQ:840947394
Email
w17362916295@163.com
Country
China
ProdList
3004
Advantage
58
Shanghai Taopu Industrial Co., LTD
Tel
159-00573766 18018507602
Email
394643792@qq.com
Country
China
ProdList
4328
Advantage
58
Gongyishengan Technology (Shenzhen) Co., Ltd.
Tel
0755-89218110 13480856786
Email
2880189130@qq.com
Country
China
ProdList
991
Advantage
58
Shaanxi DIDU pharmaceutical and Chemical Co., Ltd
Tel
029-029-029-81148696 18161915376
Email
1040@dideu.com
Country
China
ProdList
9958
Advantage
58
Pushan Industry (Shaanxi) Co., Ltd.
Tel
029-81310890 13571859809
Email
info@pushanshiye.com
Country
China
ProdList
9953
Advantage
58
Hubei Hicks Biochemical Co., Ltd
Tel
17362916295; 17362916295
Email
w17362916295@163.com
Country
China
ProdList
3992
Advantage
58
Shanghai Aoguang Biotechnology Co., Ltd
Tel
1735-4997695 17715859063
Email
1204996172@qq.com
Country
China
ProdList
288
Advantage
58
Cangzhou Enke Pharma Tech Co.,ltd.
Tel
0317-5106596 15533709196
Email
1154424302@qq.com
Country
China
ProdList
2242
Advantage
58
Adipogen Life Sciences
Tel
41-6192660-40
Email
info@adipogen.com
Country
China
ProdList
5293
Advantage
58
StressMarq Biosciences Inc
Tel
1250-294-9065
Email
info@stressmarq.com
Country
China
ProdList
3181
Advantage
58
Cayman Chemical Company
Tel
800-364-9897
Email
sales@caymanchem.com
Country
China
ProdList
6838
Advantage
58
Enzo Biochem Inc
Tel
Enzo Biochem Inc. 13797054060
Email
Enzoname@qq.com
Country
China
ProdList
6174
Advantage
58
Cell Signaling Technology Inc
Tel
21-80243558 86218024
Email
info@cellsignal.cn
Country
China
ProdList
6725
Advantage
58
Tiancheng Chemical (Jiangsu) Co., Ltd
Tel
0512-66387919 18662433356
Email
18662433356@163.com
Country
China
ProdList
10970
Advantage
58
Jiangsu Xinsu New Materials Co., Ltd
Tel
0512-66387919 15251950002
Email
15251950002@163.com
Country
China
ProdList
11046
Advantage
58
Nanxing Chemical (Jiangsu) Co., Ltd
Tel
0512-66387035 18662433356
Email
18662433356@163.com
Country
China
ProdList
10929
Advantage
58
Biosynth Biological Technology (Suzhou) Co Ltd
Tel
51288865780
Email
sales@biosynth.com
Country
China
ProdList
6051
Advantage
58
Wuhan Smike Biotechnology Co., Ltd.
Tel
18186154374
Email
2070983007@qq.com
Country
China
ProdList
4598
Advantage
58
XIAMEN AMITY INDUSTRY AND TRADE CO., LTD.
Tel
+8618950047208
Email
ellena@amitychem.com
Country
China
ProdList
43416
Advantage
58
SHANGHAI KEAN TECHNOLOGY CO., LTD.
Tel
+8613817748580
Fax
021-50175322
Email
cooperation@kean-chem.com
Country
China
ProdList
40066
Advantage
58
SUZHOU SENFEIDA CHEMICAL CO.,LTD
Tel
+86-0512-83500002 +8618662433356
Email
3899766280@qq.com
Country
China
ProdList
26362
Advantage
58
Shaanxi TNJONE Pharmaceutical Co., Ltd
Tel
+8618092446649
Email
sarah@tnjone.com
Country
China
ProdList
1143
Advantage
58
Henan Fengda Chemical Co., Ltd
Tel
+86-371-86557731 +86-13613820652
Fax
86-0371-86557731
Email
info@fdachem.com
Country
China
ProdList
20137
Advantage
58
More
Less

View Lastest Price from Verapamil hydrochloride manufacturers

WUHAN FORTUNA CHEMICAL CO., LTD
Product
Verapamil hydrochloride 23313-68-0
Price
US $0.00/KG
Min. Order
1KG
Purity
99%,USP
Supply Ability
500kg/month
Release date
2021-07-23
Shaanxi TNJONE Pharmaceutical Co., Ltd
Product
Verapamil Hydrochloride 23313-68-0
Price
US $0.00/kg
Min. Order
1kg
Purity
99%
Supply Ability
10000kg
Release date
2024-05-07
Zhuozhou Wenxi import and Export Co., Ltd
Product
Verapamil hydrochloride 23313-68-0
Price
US $15.00-10.00/KG
Min. Order
1KG
Purity
99%+ HPLC
Supply Ability
Monthly supply of 1 ton
Release date
2021-07-09

23313-68-0, Verapamil hydrochlorideRelated Search:


  • CALAN
  • IPROVERATRIL
  • (+/-)-5-[N-(3,4-DIMETHOXYPHENYLETHYL)-METHYLAMINO]-2-(3,4-DIMETHOXYPHENYL)-2-ISOPROPYLVALERONITRILE HYDROCHLORIDE
  • 5-[N-(3,4-DIMETHOXYPHENYLETHYL)METHYLAMINO]-2-(3,4-DIMETHOXYPHENYL)-2-ISOPROPYLVALERONITRILE HYDROCHLORIDE
  • alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)-benzeneacetonitrile hydrochloride
  • ALPHA-[3-[[2-(3,4-DIMETHOXYPHENYL)ETHYL]METHYLAMINO]PROPYL]-3,4-DIMETHOXY-ALPHA-(1-METHYLETHYL)BENZENEACETONITRILE HYDROCHLORIDE
  • 5-[(3,4-DIMETHOXYPHENETHYL)METHYLAMINO]-2-(3,4-DIMETHOXYPHENYL)-2-ISOPROPYL-VALERONITRILE HYDROCHLORIDE
  • (+/-)-VERAPAMIL HYDROCHLORIDE
  • VERAPAMIL HYDROCHLORIDE
  • VERAPAMIL HCL
  • ISOPTIN
  • a-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-a-(1-methylethyl)-benzeneacetonitrile Hydrochloride
  • Berkatens
  • Cardibeltin
  • Dignover
  • Veracim
  • Veramex
  • Zolvera
  • (±)-[3-cyano-3-(3,4-dimethoxyphenyl)hex-6-yl](5,6-dimethoxyphenethyl)methylammonium chloride
  • dl-Verapamil hydrochloride
  • alpha-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-alpha(1-methylethyl)benzeneacetonitrile monohydrochloride
  • 5-((3,4-diMethoxyphenethyl)(Methyl)aMino)-2-(3,4-diMethoxyphenyl)-2-isopropylpentanenitrile hydrochloride
  • Verapamil hydrochloride USP/EP/BP
  • (±)-Verapamilhydrochloride
  • 23313-68-0
  • C27H38N2O4.HCl
  • Voltage-gated Ion Channels
  • Other
  • Enzymes, Inhibitors, and Substrates
  • Enzyme Inhibitors by Type
  • Enzyme Inhibitors
  • Ion Channels
  • BioChemical
  • Biochemicals and Reagents
  • Cell Biology
  • Cell Signaling and Neuroscience
  • Calcium Channel Modulators
  • Intermediates & Fine Chemicals
  • Pharmaceuticals